BRD2 and neoplasm: Our recent study on PDAC tissue proteome profiles revealed the impact of NAT on tumor and systemic metabolism in PDAC patients, as evidenced by the markedly lower expression of metabolism‐related proteins in NAT compared to TN patients [18].